| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |